Global Anti-heat Stroke Medicine Market Growth 2025-2031
The global Anti-heat Stroke Medicine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Anti-heat Stroke Medicine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Anti-heat Stroke Medicine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Anti-heat Stroke Medicine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Anti-heat Stroke Medicine players cover Chongqing Taiji Industry (Group) Co., Ltd., Heavy Pharmaceutical Holdings, Guangdong Nanguo Pharmaceutical Co.,Ltd., Shanghai Hutchison Pharmaceuticals Ltd., CRC Benxi Sanyao Co., Ltd. Labour Union Committee, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Anti-heat Stroke Medicine Industry Forecast” looks at past sales and reviews total world Anti-heat Stroke Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-heat Stroke Medicine sales for 2025 through 2031. With Anti-heat Stroke Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-heat Stroke Medicine industry.
This Insight Report provides a comprehensive analysis of the global Anti-heat Stroke Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-heat Stroke Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-heat Stroke Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-heat Stroke Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-heat Stroke Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-heat Stroke Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Anti-heat Stroke Medicine market?
What factors are driving Anti-heat Stroke Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-heat Stroke Medicine market opportunities vary by end market size?
How does Anti-heat Stroke Medicine break out by Type, by Application?
United States market for Anti-heat Stroke Medicine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Anti-heat Stroke Medicine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Anti-heat Stroke Medicine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Anti-heat Stroke Medicine players cover Chongqing Taiji Industry (Group) Co., Ltd., Heavy Pharmaceutical Holdings, Guangdong Nanguo Pharmaceutical Co.,Ltd., Shanghai Hutchison Pharmaceuticals Ltd., CRC Benxi Sanyao Co., Ltd. Labour Union Committee, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Anti-heat Stroke Medicine Industry Forecast” looks at past sales and reviews total world Anti-heat Stroke Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-heat Stroke Medicine sales for 2025 through 2031. With Anti-heat Stroke Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-heat Stroke Medicine industry.
This Insight Report provides a comprehensive analysis of the global Anti-heat Stroke Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-heat Stroke Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-heat Stroke Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-heat Stroke Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-heat Stroke Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-heat Stroke Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Liquid Medicine
- Pill
- Capsule
- Others
- Hospital
- Clinic
- Pharmacy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chongqing Taiji Industry (Group) Co., Ltd.
- Heavy Pharmaceutical Holdings
- Guangdong Nanguo Pharmaceutical Co.,Ltd.
- Shanghai Hutchison Pharmaceuticals Ltd.
- CRC Benxi Sanyao Co., Ltd. Labour Union Committee
- Guangxi Dalishen Pharmaceutical Co., Ltd
- Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.)
- Beijing Tongrentang Co., Ltd
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Tasly Pharmaceutical Group Co., Ltd.
- Beijing Haiderun Pharmaceutical Co.Ltd.
- Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
What is the 10-year outlook for the global Anti-heat Stroke Medicine market?
What factors are driving Anti-heat Stroke Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-heat Stroke Medicine market opportunities vary by end market size?
How does Anti-heat Stroke Medicine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-heat Stroke Medicine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anti-heat Stroke Medicine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anti-heat Stroke Medicine by Country/Region, 2020, 2024 & 2031
2.2 Anti-heat Stroke Medicine Segment by Type
2.2.1 Liquid Medicine
2.2.2 Pill
2.2.3 Capsule
2.2.4 Others
2.3 Anti-heat Stroke Medicine Sales by Type
2.3.1 Global Anti-heat Stroke Medicine Sales Market Share by Type (2020-2025)
2.3.2 Global Anti-heat Stroke Medicine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anti-heat Stroke Medicine Sale Price by Type (2020-2025)
2.4 Anti-heat Stroke Medicine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.4.4 Others
2.5 Anti-heat Stroke Medicine Sales by Application
2.5.1 Global Anti-heat Stroke Medicine Sale Market Share by Application (2020-2025)
2.5.2 Global Anti-heat Stroke Medicine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anti-heat Stroke Medicine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anti-heat Stroke Medicine Breakdown Data by Company
3.1.1 Global Anti-heat Stroke Medicine Annual Sales by Company (2020-2025)
3.1.2 Global Anti-heat Stroke Medicine Sales Market Share by Company (2020-2025)
3.2 Global Anti-heat Stroke Medicine Annual Revenue by Company (2020-2025)
3.2.1 Global Anti-heat Stroke Medicine Revenue by Company (2020-2025)
3.2.2 Global Anti-heat Stroke Medicine Revenue Market Share by Company (2020-2025)
3.3 Global Anti-heat Stroke Medicine Sale Price by Company
3.4 Key Manufacturers Anti-heat Stroke Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-heat Stroke Medicine Product Location Distribution
3.4.2 Players Anti-heat Stroke Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-HEAT STROKE MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Anti-heat Stroke Medicine Market Size by Geographic Region (2020-2025)
4.1.1 Global Anti-heat Stroke Medicine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anti-heat Stroke Medicine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-heat Stroke Medicine Market Size by Country/Region (2020-2025)
4.2.1 Global Anti-heat Stroke Medicine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anti-heat Stroke Medicine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-heat Stroke Medicine Sales Growth
4.4 APAC Anti-heat Stroke Medicine Sales Growth
4.5 Europe Anti-heat Stroke Medicine Sales Growth
4.6 Middle East & Africa Anti-heat Stroke Medicine Sales Growth
5 AMERICAS
5.1 Americas Anti-heat Stroke Medicine Sales by Country
5.1.1 Americas Anti-heat Stroke Medicine Sales by Country (2020-2025)
5.1.2 Americas Anti-heat Stroke Medicine Revenue by Country (2020-2025)
5.2 Americas Anti-heat Stroke Medicine Sales by Type (2020-2025)
5.3 Americas Anti-heat Stroke Medicine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-heat Stroke Medicine Sales by Region
6.1.1 APAC Anti-heat Stroke Medicine Sales by Region (2020-2025)
6.1.2 APAC Anti-heat Stroke Medicine Revenue by Region (2020-2025)
6.2 APAC Anti-heat Stroke Medicine Sales by Type (2020-2025)
6.3 APAC Anti-heat Stroke Medicine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-heat Stroke Medicine by Country
7.1.1 Europe Anti-heat Stroke Medicine Sales by Country (2020-2025)
7.1.2 Europe Anti-heat Stroke Medicine Revenue by Country (2020-2025)
7.2 Europe Anti-heat Stroke Medicine Sales by Type (2020-2025)
7.3 Europe Anti-heat Stroke Medicine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-heat Stroke Medicine by Country
8.1.1 Middle East & Africa Anti-heat Stroke Medicine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anti-heat Stroke Medicine Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-heat Stroke Medicine Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-heat Stroke Medicine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-heat Stroke Medicine
10.3 Manufacturing Process Analysis of Anti-heat Stroke Medicine
10.4 Industry Chain Structure of Anti-heat Stroke Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-heat Stroke Medicine Distributors
11.3 Anti-heat Stroke Medicine Customer
12 WORLD FORECAST REVIEW FOR ANTI-HEAT STROKE MEDICINE BY GEOGRAPHIC REGION
12.1 Global Anti-heat Stroke Medicine Market Size Forecast by Region
12.1.1 Global Anti-heat Stroke Medicine Forecast by Region (2026-2031)
12.1.2 Global Anti-heat Stroke Medicine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-heat Stroke Medicine Forecast by Type (2026-2031)
12.7 Global Anti-heat Stroke Medicine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Chongqing Taiji Industry (Group) Co., Ltd.
13.1.1 Chongqing Taiji Industry (Group) Co., Ltd. Company Information
13.1.2 Chongqing Taiji Industry (Group) Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.1.3 Chongqing Taiji Industry (Group) Co., Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Chongqing Taiji Industry (Group) Co., Ltd. Main Business Overview
13.1.5 Chongqing Taiji Industry (Group) Co., Ltd. Latest Developments
13.2 Heavy Pharmaceutical Holdings
13.2.1 Heavy Pharmaceutical Holdings Company Information
13.2.2 Heavy Pharmaceutical Holdings Anti-heat Stroke Medicine Product Portfolios and Specifications
13.2.3 Heavy Pharmaceutical Holdings Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Heavy Pharmaceutical Holdings Main Business Overview
13.2.5 Heavy Pharmaceutical Holdings Latest Developments
13.3 Guangdong Nanguo Pharmaceutical Co.,Ltd.
13.3.1 Guangdong Nanguo Pharmaceutical Co.,Ltd. Company Information
13.3.2 Guangdong Nanguo Pharmaceutical Co.,Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.3.3 Guangdong Nanguo Pharmaceutical Co.,Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Guangdong Nanguo Pharmaceutical Co.,Ltd. Main Business Overview
13.3.5 Guangdong Nanguo Pharmaceutical Co.,Ltd. Latest Developments
13.4 Shanghai Hutchison Pharmaceuticals Ltd.
13.4.1 Shanghai Hutchison Pharmaceuticals Ltd. Company Information
13.4.2 Shanghai Hutchison Pharmaceuticals Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.4.3 Shanghai Hutchison Pharmaceuticals Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Shanghai Hutchison Pharmaceuticals Ltd. Main Business Overview
13.4.5 Shanghai Hutchison Pharmaceuticals Ltd. Latest Developments
13.5 CRC Benxi Sanyao Co., Ltd. Labour Union Committee
13.5.1 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Company Information
13.5.2 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Anti-heat Stroke Medicine Product Portfolios and Specifications
13.5.3 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Main Business Overview
13.5.5 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Latest Developments
13.6 Guangxi Dalishen Pharmaceutical Co., Ltd
13.6.1 Guangxi Dalishen Pharmaceutical Co., Ltd Company Information
13.6.2 Guangxi Dalishen Pharmaceutical Co., Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
13.6.3 Guangxi Dalishen Pharmaceutical Co., Ltd Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Guangxi Dalishen Pharmaceutical Co., Ltd Main Business Overview
13.6.5 Guangxi Dalishen Pharmaceutical Co., Ltd Latest Developments
13.7 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.)
13.7.1 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Company Information
13.7.2 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Anti-heat Stroke Medicine Product Portfolios and Specifications
13.7.3 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Main Business Overview
13.7.5 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Latest Developments
13.8 Beijing Tongrentang Co., Ltd
13.8.1 Beijing Tongrentang Co., Ltd Company Information
13.8.2 Beijing Tongrentang Co., Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
13.8.3 Beijing Tongrentang Co., Ltd Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Beijing Tongrentang Co., Ltd Main Business Overview
13.8.5 Beijing Tongrentang Co., Ltd Latest Developments
13.9 CSPC Ouyi Pharmaceutical Co., Ltd.
13.9.1 CSPC Ouyi Pharmaceutical Co., Ltd. Company Information
13.9.2 CSPC Ouyi Pharmaceutical Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.9.3 CSPC Ouyi Pharmaceutical Co., Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 CSPC Ouyi Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 CSPC Ouyi Pharmaceutical Co., Ltd. Latest Developments
13.10 Tasly Pharmaceutical Group Co., Ltd.
13.10.1 Tasly Pharmaceutical Group Co., Ltd. Company Information
13.10.2 Tasly Pharmaceutical Group Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.10.3 Tasly Pharmaceutical Group Co., Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Tasly Pharmaceutical Group Co., Ltd. Main Business Overview
13.10.5 Tasly Pharmaceutical Group Co., Ltd. Latest Developments
13.11 Beijing Haiderun Pharmaceutical Co.Ltd.
13.11.1 Beijing Haiderun Pharmaceutical Co.Ltd. Company Information
13.11.2 Beijing Haiderun Pharmaceutical Co.Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.11.3 Beijing Haiderun Pharmaceutical Co.Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Beijing Haiderun Pharmaceutical Co.Ltd. Main Business Overview
13.11.5 Beijing Haiderun Pharmaceutical Co.Ltd. Latest Developments
13.12 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
13.12.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information
13.12.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
13.12.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Main Business Overview
13.12.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-heat Stroke Medicine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anti-heat Stroke Medicine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anti-heat Stroke Medicine by Country/Region, 2020, 2024 & 2031
2.2 Anti-heat Stroke Medicine Segment by Type
2.2.1 Liquid Medicine
2.2.2 Pill
2.2.3 Capsule
2.2.4 Others
2.3 Anti-heat Stroke Medicine Sales by Type
2.3.1 Global Anti-heat Stroke Medicine Sales Market Share by Type (2020-2025)
2.3.2 Global Anti-heat Stroke Medicine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anti-heat Stroke Medicine Sale Price by Type (2020-2025)
2.4 Anti-heat Stroke Medicine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.4.4 Others
2.5 Anti-heat Stroke Medicine Sales by Application
2.5.1 Global Anti-heat Stroke Medicine Sale Market Share by Application (2020-2025)
2.5.2 Global Anti-heat Stroke Medicine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anti-heat Stroke Medicine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anti-heat Stroke Medicine Breakdown Data by Company
3.1.1 Global Anti-heat Stroke Medicine Annual Sales by Company (2020-2025)
3.1.2 Global Anti-heat Stroke Medicine Sales Market Share by Company (2020-2025)
3.2 Global Anti-heat Stroke Medicine Annual Revenue by Company (2020-2025)
3.2.1 Global Anti-heat Stroke Medicine Revenue by Company (2020-2025)
3.2.2 Global Anti-heat Stroke Medicine Revenue Market Share by Company (2020-2025)
3.3 Global Anti-heat Stroke Medicine Sale Price by Company
3.4 Key Manufacturers Anti-heat Stroke Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-heat Stroke Medicine Product Location Distribution
3.4.2 Players Anti-heat Stroke Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-HEAT STROKE MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Anti-heat Stroke Medicine Market Size by Geographic Region (2020-2025)
4.1.1 Global Anti-heat Stroke Medicine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anti-heat Stroke Medicine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-heat Stroke Medicine Market Size by Country/Region (2020-2025)
4.2.1 Global Anti-heat Stroke Medicine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anti-heat Stroke Medicine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-heat Stroke Medicine Sales Growth
4.4 APAC Anti-heat Stroke Medicine Sales Growth
4.5 Europe Anti-heat Stroke Medicine Sales Growth
4.6 Middle East & Africa Anti-heat Stroke Medicine Sales Growth
5 AMERICAS
5.1 Americas Anti-heat Stroke Medicine Sales by Country
5.1.1 Americas Anti-heat Stroke Medicine Sales by Country (2020-2025)
5.1.2 Americas Anti-heat Stroke Medicine Revenue by Country (2020-2025)
5.2 Americas Anti-heat Stroke Medicine Sales by Type (2020-2025)
5.3 Americas Anti-heat Stroke Medicine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-heat Stroke Medicine Sales by Region
6.1.1 APAC Anti-heat Stroke Medicine Sales by Region (2020-2025)
6.1.2 APAC Anti-heat Stroke Medicine Revenue by Region (2020-2025)
6.2 APAC Anti-heat Stroke Medicine Sales by Type (2020-2025)
6.3 APAC Anti-heat Stroke Medicine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-heat Stroke Medicine by Country
7.1.1 Europe Anti-heat Stroke Medicine Sales by Country (2020-2025)
7.1.2 Europe Anti-heat Stroke Medicine Revenue by Country (2020-2025)
7.2 Europe Anti-heat Stroke Medicine Sales by Type (2020-2025)
7.3 Europe Anti-heat Stroke Medicine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-heat Stroke Medicine by Country
8.1.1 Middle East & Africa Anti-heat Stroke Medicine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anti-heat Stroke Medicine Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-heat Stroke Medicine Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-heat Stroke Medicine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-heat Stroke Medicine
10.3 Manufacturing Process Analysis of Anti-heat Stroke Medicine
10.4 Industry Chain Structure of Anti-heat Stroke Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-heat Stroke Medicine Distributors
11.3 Anti-heat Stroke Medicine Customer
12 WORLD FORECAST REVIEW FOR ANTI-HEAT STROKE MEDICINE BY GEOGRAPHIC REGION
12.1 Global Anti-heat Stroke Medicine Market Size Forecast by Region
12.1.1 Global Anti-heat Stroke Medicine Forecast by Region (2026-2031)
12.1.2 Global Anti-heat Stroke Medicine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-heat Stroke Medicine Forecast by Type (2026-2031)
12.7 Global Anti-heat Stroke Medicine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Chongqing Taiji Industry (Group) Co., Ltd.
13.1.1 Chongqing Taiji Industry (Group) Co., Ltd. Company Information
13.1.2 Chongqing Taiji Industry (Group) Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.1.3 Chongqing Taiji Industry (Group) Co., Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Chongqing Taiji Industry (Group) Co., Ltd. Main Business Overview
13.1.5 Chongqing Taiji Industry (Group) Co., Ltd. Latest Developments
13.2 Heavy Pharmaceutical Holdings
13.2.1 Heavy Pharmaceutical Holdings Company Information
13.2.2 Heavy Pharmaceutical Holdings Anti-heat Stroke Medicine Product Portfolios and Specifications
13.2.3 Heavy Pharmaceutical Holdings Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Heavy Pharmaceutical Holdings Main Business Overview
13.2.5 Heavy Pharmaceutical Holdings Latest Developments
13.3 Guangdong Nanguo Pharmaceutical Co.,Ltd.
13.3.1 Guangdong Nanguo Pharmaceutical Co.,Ltd. Company Information
13.3.2 Guangdong Nanguo Pharmaceutical Co.,Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.3.3 Guangdong Nanguo Pharmaceutical Co.,Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Guangdong Nanguo Pharmaceutical Co.,Ltd. Main Business Overview
13.3.5 Guangdong Nanguo Pharmaceutical Co.,Ltd. Latest Developments
13.4 Shanghai Hutchison Pharmaceuticals Ltd.
13.4.1 Shanghai Hutchison Pharmaceuticals Ltd. Company Information
13.4.2 Shanghai Hutchison Pharmaceuticals Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.4.3 Shanghai Hutchison Pharmaceuticals Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Shanghai Hutchison Pharmaceuticals Ltd. Main Business Overview
13.4.5 Shanghai Hutchison Pharmaceuticals Ltd. Latest Developments
13.5 CRC Benxi Sanyao Co., Ltd. Labour Union Committee
13.5.1 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Company Information
13.5.2 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Anti-heat Stroke Medicine Product Portfolios and Specifications
13.5.3 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Main Business Overview
13.5.5 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Latest Developments
13.6 Guangxi Dalishen Pharmaceutical Co., Ltd
13.6.1 Guangxi Dalishen Pharmaceutical Co., Ltd Company Information
13.6.2 Guangxi Dalishen Pharmaceutical Co., Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
13.6.3 Guangxi Dalishen Pharmaceutical Co., Ltd Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Guangxi Dalishen Pharmaceutical Co., Ltd Main Business Overview
13.6.5 Guangxi Dalishen Pharmaceutical Co., Ltd Latest Developments
13.7 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.)
13.7.1 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Company Information
13.7.2 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Anti-heat Stroke Medicine Product Portfolios and Specifications
13.7.3 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Main Business Overview
13.7.5 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Latest Developments
13.8 Beijing Tongrentang Co., Ltd
13.8.1 Beijing Tongrentang Co., Ltd Company Information
13.8.2 Beijing Tongrentang Co., Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
13.8.3 Beijing Tongrentang Co., Ltd Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Beijing Tongrentang Co., Ltd Main Business Overview
13.8.5 Beijing Tongrentang Co., Ltd Latest Developments
13.9 CSPC Ouyi Pharmaceutical Co., Ltd.
13.9.1 CSPC Ouyi Pharmaceutical Co., Ltd. Company Information
13.9.2 CSPC Ouyi Pharmaceutical Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.9.3 CSPC Ouyi Pharmaceutical Co., Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 CSPC Ouyi Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 CSPC Ouyi Pharmaceutical Co., Ltd. Latest Developments
13.10 Tasly Pharmaceutical Group Co., Ltd.
13.10.1 Tasly Pharmaceutical Group Co., Ltd. Company Information
13.10.2 Tasly Pharmaceutical Group Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.10.3 Tasly Pharmaceutical Group Co., Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Tasly Pharmaceutical Group Co., Ltd. Main Business Overview
13.10.5 Tasly Pharmaceutical Group Co., Ltd. Latest Developments
13.11 Beijing Haiderun Pharmaceutical Co.Ltd.
13.11.1 Beijing Haiderun Pharmaceutical Co.Ltd. Company Information
13.11.2 Beijing Haiderun Pharmaceutical Co.Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.11.3 Beijing Haiderun Pharmaceutical Co.Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Beijing Haiderun Pharmaceutical Co.Ltd. Main Business Overview
13.11.5 Beijing Haiderun Pharmaceutical Co.Ltd. Latest Developments
13.12 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
13.12.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information
13.12.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
13.12.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Main Business Overview
13.12.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-heat Stroke Medicine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-heat Stroke Medicine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liquid Medicine
Table 4. Major Players of Pill
Table 5. Major Players of Capsule
Table 6. Major Players of Others
Table 7. Global Anti-heat Stroke Medicine Sales by Type (2020-2025) & (K Units)
Table 8. Global Anti-heat Stroke Medicine Sales Market Share by Type (2020-2025)
Table 9. Global Anti-heat Stroke Medicine Revenue by Type (2020-2025) & ($ million)
Table 10. Global Anti-heat Stroke Medicine Revenue Market Share by Type (2020-2025)
Table 11. Global Anti-heat Stroke Medicine Sale Price by Type (2020-2025) & (US$/Unit)
Table 12. Global Anti-heat Stroke Medicine Sale by Application (2020-2025) & (K Units)
Table 13. Global Anti-heat Stroke Medicine Sale Market Share by Application (2020-2025)
Table 14. Global Anti-heat Stroke Medicine Revenue by Application (2020-2025) & ($ million)
Table 15. Global Anti-heat Stroke Medicine Revenue Market Share by Application (2020-2025)
Table 16. Global Anti-heat Stroke Medicine Sale Price by Application (2020-2025) & (US$/Unit)
Table 17. Global Anti-heat Stroke Medicine Sales by Company (2020-2025) & (K Units)
Table 18. Global Anti-heat Stroke Medicine Sales Market Share by Company (2020-2025)
Table 19. Global Anti-heat Stroke Medicine Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Anti-heat Stroke Medicine Revenue Market Share by Company (2020-2025)
Table 21. Global Anti-heat Stroke Medicine Sale Price by Company (2020-2025) & (US$/Unit)
Table 22. Key Manufacturers Anti-heat Stroke Medicine Producing Area Distribution and Sales Area
Table 23. Players Anti-heat Stroke Medicine Products Offered
Table 24. Anti-heat Stroke Medicine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Anti-heat Stroke Medicine Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Anti-heat Stroke Medicine Sales Market Share Geographic Region (2020-2025)
Table 29. Global Anti-heat Stroke Medicine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Anti-heat Stroke Medicine Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Anti-heat Stroke Medicine Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Anti-heat Stroke Medicine Sales Market Share by Country/Region (2020-2025)
Table 33. Global Anti-heat Stroke Medicine Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Anti-heat Stroke Medicine Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Anti-heat Stroke Medicine Sales by Country (2020-2025) & (K Units)
Table 36. Americas Anti-heat Stroke Medicine Sales Market Share by Country (2020-2025)
Table 37. Americas Anti-heat Stroke Medicine Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Anti-heat Stroke Medicine Sales by Type (2020-2025) & (K Units)
Table 39. Americas Anti-heat Stroke Medicine Sales by Application (2020-2025) & (K Units)
Table 40. APAC Anti-heat Stroke Medicine Sales by Region (2020-2025) & (K Units)
Table 41. APAC Anti-heat Stroke Medicine Sales Market Share by Region (2020-2025)
Table 42. APAC Anti-heat Stroke Medicine Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Anti-heat Stroke Medicine Sales by Type (2020-2025) & (K Units)
Table 44. APAC Anti-heat Stroke Medicine Sales by Application (2020-2025) & (K Units)
Table 45. Europe Anti-heat Stroke Medicine Sales by Country (2020-2025) & (K Units)
Table 46. Europe Anti-heat Stroke Medicine Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Anti-heat Stroke Medicine Sales by Type (2020-2025) & (K Units)
Table 48. Europe Anti-heat Stroke Medicine Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Anti-heat Stroke Medicine Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Anti-heat Stroke Medicine Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Anti-heat Stroke Medicine Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Anti-heat Stroke Medicine Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Anti-heat Stroke Medicine
Table 54. Key Market Challenges & Risks of Anti-heat Stroke Medicine
Table 55. Key Industry Trends of Anti-heat Stroke Medicine
Table 56. Anti-heat Stroke Medicine Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Anti-heat Stroke Medicine Distributors List
Table 59. Anti-heat Stroke Medicine Customer List
Table 60. Global Anti-heat Stroke Medicine Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Anti-heat Stroke Medicine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Anti-heat Stroke Medicine Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Anti-heat Stroke Medicine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Anti-heat Stroke Medicine Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Anti-heat Stroke Medicine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Anti-heat Stroke Medicine Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Anti-heat Stroke Medicine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Anti-heat Stroke Medicine Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Anti-heat Stroke Medicine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Anti-heat Stroke Medicine Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Anti-heat Stroke Medicine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Anti-heat Stroke Medicine Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Anti-heat Stroke Medicine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Chongqing Taiji Industry (Group) Co., Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 75. Chongqing Taiji Industry (Group) Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 76. Chongqing Taiji Industry (Group) Co., Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 77. Chongqing Taiji Industry (Group) Co., Ltd. Main Business
Table 78. Chongqing Taiji Industry (Group) Co., Ltd. Latest Developments
Table 79. Heavy Pharmaceutical Holdings Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 80. Heavy Pharmaceutical Holdings Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 81. Heavy Pharmaceutical Holdings Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 82. Heavy Pharmaceutical Holdings Main Business
Table 83. Heavy Pharmaceutical Holdings Latest Developments
Table 84. Guangdong Nanguo Pharmaceutical Co.,Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 85. Guangdong Nanguo Pharmaceutical Co.,Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 86. Guangdong Nanguo Pharmaceutical Co.,Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 87. Guangdong Nanguo Pharmaceutical Co.,Ltd. Main Business
Table 88. Guangdong Nanguo Pharmaceutical Co.,Ltd. Latest Developments
Table 89. Shanghai Hutchison Pharmaceuticals Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 90. Shanghai Hutchison Pharmaceuticals Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 91. Shanghai Hutchison Pharmaceuticals Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 92. Shanghai Hutchison Pharmaceuticals Ltd. Main Business
Table 93. Shanghai Hutchison Pharmaceuticals Ltd. Latest Developments
Table 94. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 95. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 96. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 97. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Main Business
Table 98. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Latest Developments
Table 99. Guangxi Dalishen Pharmaceutical Co., Ltd Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 100. Guangxi Dalishen Pharmaceutical Co., Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 101. Guangxi Dalishen Pharmaceutical Co., Ltd Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. Guangxi Dalishen Pharmaceutical Co., Ltd Main Business
Table 103. Guangxi Dalishen Pharmaceutical Co., Ltd Latest Developments
Table 104. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 105. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 106. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 107. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Main Business
Table 108. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Latest Developments
Table 109. Beijing Tongrentang Co., Ltd Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 110. Beijing Tongrentang Co., Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 111. Beijing Tongrentang Co., Ltd Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Beijing Tongrentang Co., Ltd Main Business
Table 113. Beijing Tongrentang Co., Ltd Latest Developments
Table 114. CSPC Ouyi Pharmaceutical Co., Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 115. CSPC Ouyi Pharmaceutical Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 116. CSPC Ouyi Pharmaceutical Co., Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 117. CSPC Ouyi Pharmaceutical Co., Ltd. Main Business
Table 118. CSPC Ouyi Pharmaceutical Co., Ltd. Latest Developments
Table 119. Tasly Pharmaceutical Group Co., Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 120. Tasly Pharmaceutical Group Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 121. Tasly Pharmaceutical Group Co., Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 122. Tasly Pharmaceutical Group Co., Ltd. Main Business
Table 123. Tasly Pharmaceutical Group Co., Ltd. Latest Developments
Table 124. Beijing Haiderun Pharmaceutical Co.Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 125. Beijing Haiderun Pharmaceutical Co.Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 126. Beijing Haiderun Pharmaceutical Co.Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 127. Beijing Haiderun Pharmaceutical Co.Ltd. Main Business
Table 128. Beijing Haiderun Pharmaceutical Co.Ltd. Latest Developments
Table 129. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 130. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 131. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 132. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Main Business
Table 133. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Latest Developments
Table 1. Anti-heat Stroke Medicine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-heat Stroke Medicine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liquid Medicine
Table 4. Major Players of Pill
Table 5. Major Players of Capsule
Table 6. Major Players of Others
Table 7. Global Anti-heat Stroke Medicine Sales by Type (2020-2025) & (K Units)
Table 8. Global Anti-heat Stroke Medicine Sales Market Share by Type (2020-2025)
Table 9. Global Anti-heat Stroke Medicine Revenue by Type (2020-2025) & ($ million)
Table 10. Global Anti-heat Stroke Medicine Revenue Market Share by Type (2020-2025)
Table 11. Global Anti-heat Stroke Medicine Sale Price by Type (2020-2025) & (US$/Unit)
Table 12. Global Anti-heat Stroke Medicine Sale by Application (2020-2025) & (K Units)
Table 13. Global Anti-heat Stroke Medicine Sale Market Share by Application (2020-2025)
Table 14. Global Anti-heat Stroke Medicine Revenue by Application (2020-2025) & ($ million)
Table 15. Global Anti-heat Stroke Medicine Revenue Market Share by Application (2020-2025)
Table 16. Global Anti-heat Stroke Medicine Sale Price by Application (2020-2025) & (US$/Unit)
Table 17. Global Anti-heat Stroke Medicine Sales by Company (2020-2025) & (K Units)
Table 18. Global Anti-heat Stroke Medicine Sales Market Share by Company (2020-2025)
Table 19. Global Anti-heat Stroke Medicine Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Anti-heat Stroke Medicine Revenue Market Share by Company (2020-2025)
Table 21. Global Anti-heat Stroke Medicine Sale Price by Company (2020-2025) & (US$/Unit)
Table 22. Key Manufacturers Anti-heat Stroke Medicine Producing Area Distribution and Sales Area
Table 23. Players Anti-heat Stroke Medicine Products Offered
Table 24. Anti-heat Stroke Medicine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Anti-heat Stroke Medicine Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Anti-heat Stroke Medicine Sales Market Share Geographic Region (2020-2025)
Table 29. Global Anti-heat Stroke Medicine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Anti-heat Stroke Medicine Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Anti-heat Stroke Medicine Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Anti-heat Stroke Medicine Sales Market Share by Country/Region (2020-2025)
Table 33. Global Anti-heat Stroke Medicine Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Anti-heat Stroke Medicine Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Anti-heat Stroke Medicine Sales by Country (2020-2025) & (K Units)
Table 36. Americas Anti-heat Stroke Medicine Sales Market Share by Country (2020-2025)
Table 37. Americas Anti-heat Stroke Medicine Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Anti-heat Stroke Medicine Sales by Type (2020-2025) & (K Units)
Table 39. Americas Anti-heat Stroke Medicine Sales by Application (2020-2025) & (K Units)
Table 40. APAC Anti-heat Stroke Medicine Sales by Region (2020-2025) & (K Units)
Table 41. APAC Anti-heat Stroke Medicine Sales Market Share by Region (2020-2025)
Table 42. APAC Anti-heat Stroke Medicine Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Anti-heat Stroke Medicine Sales by Type (2020-2025) & (K Units)
Table 44. APAC Anti-heat Stroke Medicine Sales by Application (2020-2025) & (K Units)
Table 45. Europe Anti-heat Stroke Medicine Sales by Country (2020-2025) & (K Units)
Table 46. Europe Anti-heat Stroke Medicine Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Anti-heat Stroke Medicine Sales by Type (2020-2025) & (K Units)
Table 48. Europe Anti-heat Stroke Medicine Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Anti-heat Stroke Medicine Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Anti-heat Stroke Medicine Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Anti-heat Stroke Medicine Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Anti-heat Stroke Medicine Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Anti-heat Stroke Medicine
Table 54. Key Market Challenges & Risks of Anti-heat Stroke Medicine
Table 55. Key Industry Trends of Anti-heat Stroke Medicine
Table 56. Anti-heat Stroke Medicine Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Anti-heat Stroke Medicine Distributors List
Table 59. Anti-heat Stroke Medicine Customer List
Table 60. Global Anti-heat Stroke Medicine Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Anti-heat Stroke Medicine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Anti-heat Stroke Medicine Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Anti-heat Stroke Medicine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Anti-heat Stroke Medicine Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Anti-heat Stroke Medicine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Anti-heat Stroke Medicine Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Anti-heat Stroke Medicine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Anti-heat Stroke Medicine Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Anti-heat Stroke Medicine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Anti-heat Stroke Medicine Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Anti-heat Stroke Medicine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Anti-heat Stroke Medicine Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Anti-heat Stroke Medicine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Chongqing Taiji Industry (Group) Co., Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 75. Chongqing Taiji Industry (Group) Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 76. Chongqing Taiji Industry (Group) Co., Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 77. Chongqing Taiji Industry (Group) Co., Ltd. Main Business
Table 78. Chongqing Taiji Industry (Group) Co., Ltd. Latest Developments
Table 79. Heavy Pharmaceutical Holdings Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 80. Heavy Pharmaceutical Holdings Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 81. Heavy Pharmaceutical Holdings Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 82. Heavy Pharmaceutical Holdings Main Business
Table 83. Heavy Pharmaceutical Holdings Latest Developments
Table 84. Guangdong Nanguo Pharmaceutical Co.,Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 85. Guangdong Nanguo Pharmaceutical Co.,Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 86. Guangdong Nanguo Pharmaceutical Co.,Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 87. Guangdong Nanguo Pharmaceutical Co.,Ltd. Main Business
Table 88. Guangdong Nanguo Pharmaceutical Co.,Ltd. Latest Developments
Table 89. Shanghai Hutchison Pharmaceuticals Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 90. Shanghai Hutchison Pharmaceuticals Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 91. Shanghai Hutchison Pharmaceuticals Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 92. Shanghai Hutchison Pharmaceuticals Ltd. Main Business
Table 93. Shanghai Hutchison Pharmaceuticals Ltd. Latest Developments
Table 94. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 95. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 96. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 97. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Main Business
Table 98. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Latest Developments
Table 99. Guangxi Dalishen Pharmaceutical Co., Ltd Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 100. Guangxi Dalishen Pharmaceutical Co., Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 101. Guangxi Dalishen Pharmaceutical Co., Ltd Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. Guangxi Dalishen Pharmaceutical Co., Ltd Main Business
Table 103. Guangxi Dalishen Pharmaceutical Co., Ltd Latest Developments
Table 104. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 105. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 106. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 107. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Main Business
Table 108. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Latest Developments
Table 109. Beijing Tongrentang Co., Ltd Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 110. Beijing Tongrentang Co., Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 111. Beijing Tongrentang Co., Ltd Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Beijing Tongrentang Co., Ltd Main Business
Table 113. Beijing Tongrentang Co., Ltd Latest Developments
Table 114. CSPC Ouyi Pharmaceutical Co., Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 115. CSPC Ouyi Pharmaceutical Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 116. CSPC Ouyi Pharmaceutical Co., Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 117. CSPC Ouyi Pharmaceutical Co., Ltd. Main Business
Table 118. CSPC Ouyi Pharmaceutical Co., Ltd. Latest Developments
Table 119. Tasly Pharmaceutical Group Co., Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 120. Tasly Pharmaceutical Group Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 121. Tasly Pharmaceutical Group Co., Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 122. Tasly Pharmaceutical Group Co., Ltd. Main Business
Table 123. Tasly Pharmaceutical Group Co., Ltd. Latest Developments
Table 124. Beijing Haiderun Pharmaceutical Co.Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 125. Beijing Haiderun Pharmaceutical Co.Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 126. Beijing Haiderun Pharmaceutical Co.Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 127. Beijing Haiderun Pharmaceutical Co.Ltd. Main Business
Table 128. Beijing Haiderun Pharmaceutical Co.Ltd. Latest Developments
Table 129. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 130. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 131. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 132. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Main Business
Table 133. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-heat Stroke Medicine
Figure 2. Anti-heat Stroke Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-heat Stroke Medicine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Anti-heat Stroke Medicine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-heat Stroke Medicine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-heat Stroke Medicine Sales Market Share by Country/Region (2024)
Figure 10. Anti-heat Stroke Medicine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liquid Medicine
Figure 12. Product Picture of Pill
Figure 13. Product Picture of Capsule
Figure 14. Product Picture of Others
Figure 15. Global Anti-heat Stroke Medicine Sales Market Share by Type in 2025
Figure 16. Global Anti-heat Stroke Medicine Revenue Market Share by Type (2020-2025)
Figure 17. Anti-heat Stroke Medicine Consumed in Hospital
Figure 18. Global Anti-heat Stroke Medicine Market: Hospital (2020-2025) & (K Units)
Figure 19. Anti-heat Stroke Medicine Consumed in Clinic
Figure 20. Global Anti-heat Stroke Medicine Market: Clinic (2020-2025) & (K Units)
Figure 21. Anti-heat Stroke Medicine Consumed in Pharmacy
Figure 22. Global Anti-heat Stroke Medicine Market: Pharmacy (2020-2025) & (K Units)
Figure 23. Anti-heat Stroke Medicine Consumed in Others
Figure 24. Global Anti-heat Stroke Medicine Market: Others (2020-2025) & (K Units)
Figure 25. Global Anti-heat Stroke Medicine Sale Market Share by Application (2024)
Figure 26. Global Anti-heat Stroke Medicine Revenue Market Share by Application in 2025
Figure 27. Anti-heat Stroke Medicine Sales by Company in 2025 (K Units)
Figure 28. Global Anti-heat Stroke Medicine Sales Market Share by Company in 2025
Figure 29. Anti-heat Stroke Medicine Revenue by Company in 2025 ($ millions)
Figure 30. Global Anti-heat Stroke Medicine Revenue Market Share by Company in 2025
Figure 31. Global Anti-heat Stroke Medicine Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Anti-heat Stroke Medicine Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Anti-heat Stroke Medicine Sales 2020-2025 (K Units)
Figure 34. Americas Anti-heat Stroke Medicine Revenue 2020-2025 ($ millions)
Figure 35. APAC Anti-heat Stroke Medicine Sales 2020-2025 (K Units)
Figure 36. APAC Anti-heat Stroke Medicine Revenue 2020-2025 ($ millions)
Figure 37. Europe Anti-heat Stroke Medicine Sales 2020-2025 (K Units)
Figure 38. Europe Anti-heat Stroke Medicine Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Anti-heat Stroke Medicine Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Anti-heat Stroke Medicine Revenue 2020-2025 ($ millions)
Figure 41. Americas Anti-heat Stroke Medicine Sales Market Share by Country in 2025
Figure 42. Americas Anti-heat Stroke Medicine Revenue Market Share by Country (2020-2025)
Figure 43. Americas Anti-heat Stroke Medicine Sales Market Share by Type (2020-2025)
Figure 44. Americas Anti-heat Stroke Medicine Sales Market Share by Application (2020-2025)
Figure 45. United States Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Anti-heat Stroke Medicine Sales Market Share by Region in 2025
Figure 50. APAC Anti-heat Stroke Medicine Revenue Market Share by Region (2020-2025)
Figure 51. APAC Anti-heat Stroke Medicine Sales Market Share by Type (2020-2025)
Figure 52. APAC Anti-heat Stroke Medicine Sales Market Share by Application (2020-2025)
Figure 53. China Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 57. India Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Anti-heat Stroke Medicine Sales Market Share by Country in 2025
Figure 61. Europe Anti-heat Stroke Medicine Revenue Market Share by Country (2020-2025)
Figure 62. Europe Anti-heat Stroke Medicine Sales Market Share by Type (2020-2025)
Figure 63. Europe Anti-heat Stroke Medicine Sales Market Share by Application (2020-2025)
Figure 64. Germany Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 65. France Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Anti-heat Stroke Medicine Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Anti-heat Stroke Medicine Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Anti-heat Stroke Medicine Sales Market Share by Application (2020-2025)
Figure 72. Egypt Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Anti-heat Stroke Medicine in 2025
Figure 78. Manufacturing Process Analysis of Anti-heat Stroke Medicine
Figure 79. Industry Chain Structure of Anti-heat Stroke Medicine
Figure 80. Channels of Distribution
Figure 81. Global Anti-heat Stroke Medicine Sales Market Forecast by Region (2026-2031)
Figure 82. Global Anti-heat Stroke Medicine Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Anti-heat Stroke Medicine Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Anti-heat Stroke Medicine Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Anti-heat Stroke Medicine Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Anti-heat Stroke Medicine Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Anti-heat Stroke Medicine
Figure 2. Anti-heat Stroke Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-heat Stroke Medicine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Anti-heat Stroke Medicine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-heat Stroke Medicine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-heat Stroke Medicine Sales Market Share by Country/Region (2024)
Figure 10. Anti-heat Stroke Medicine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liquid Medicine
Figure 12. Product Picture of Pill
Figure 13. Product Picture of Capsule
Figure 14. Product Picture of Others
Figure 15. Global Anti-heat Stroke Medicine Sales Market Share by Type in 2025
Figure 16. Global Anti-heat Stroke Medicine Revenue Market Share by Type (2020-2025)
Figure 17. Anti-heat Stroke Medicine Consumed in Hospital
Figure 18. Global Anti-heat Stroke Medicine Market: Hospital (2020-2025) & (K Units)
Figure 19. Anti-heat Stroke Medicine Consumed in Clinic
Figure 20. Global Anti-heat Stroke Medicine Market: Clinic (2020-2025) & (K Units)
Figure 21. Anti-heat Stroke Medicine Consumed in Pharmacy
Figure 22. Global Anti-heat Stroke Medicine Market: Pharmacy (2020-2025) & (K Units)
Figure 23. Anti-heat Stroke Medicine Consumed in Others
Figure 24. Global Anti-heat Stroke Medicine Market: Others (2020-2025) & (K Units)
Figure 25. Global Anti-heat Stroke Medicine Sale Market Share by Application (2024)
Figure 26. Global Anti-heat Stroke Medicine Revenue Market Share by Application in 2025
Figure 27. Anti-heat Stroke Medicine Sales by Company in 2025 (K Units)
Figure 28. Global Anti-heat Stroke Medicine Sales Market Share by Company in 2025
Figure 29. Anti-heat Stroke Medicine Revenue by Company in 2025 ($ millions)
Figure 30. Global Anti-heat Stroke Medicine Revenue Market Share by Company in 2025
Figure 31. Global Anti-heat Stroke Medicine Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Anti-heat Stroke Medicine Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Anti-heat Stroke Medicine Sales 2020-2025 (K Units)
Figure 34. Americas Anti-heat Stroke Medicine Revenue 2020-2025 ($ millions)
Figure 35. APAC Anti-heat Stroke Medicine Sales 2020-2025 (K Units)
Figure 36. APAC Anti-heat Stroke Medicine Revenue 2020-2025 ($ millions)
Figure 37. Europe Anti-heat Stroke Medicine Sales 2020-2025 (K Units)
Figure 38. Europe Anti-heat Stroke Medicine Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Anti-heat Stroke Medicine Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Anti-heat Stroke Medicine Revenue 2020-2025 ($ millions)
Figure 41. Americas Anti-heat Stroke Medicine Sales Market Share by Country in 2025
Figure 42. Americas Anti-heat Stroke Medicine Revenue Market Share by Country (2020-2025)
Figure 43. Americas Anti-heat Stroke Medicine Sales Market Share by Type (2020-2025)
Figure 44. Americas Anti-heat Stroke Medicine Sales Market Share by Application (2020-2025)
Figure 45. United States Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Anti-heat Stroke Medicine Sales Market Share by Region in 2025
Figure 50. APAC Anti-heat Stroke Medicine Revenue Market Share by Region (2020-2025)
Figure 51. APAC Anti-heat Stroke Medicine Sales Market Share by Type (2020-2025)
Figure 52. APAC Anti-heat Stroke Medicine Sales Market Share by Application (2020-2025)
Figure 53. China Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 57. India Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Anti-heat Stroke Medicine Sales Market Share by Country in 2025
Figure 61. Europe Anti-heat Stroke Medicine Revenue Market Share by Country (2020-2025)
Figure 62. Europe Anti-heat Stroke Medicine Sales Market Share by Type (2020-2025)
Figure 63. Europe Anti-heat Stroke Medicine Sales Market Share by Application (2020-2025)
Figure 64. Germany Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 65. France Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Anti-heat Stroke Medicine Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Anti-heat Stroke Medicine Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Anti-heat Stroke Medicine Sales Market Share by Application (2020-2025)
Figure 72. Egypt Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Anti-heat Stroke Medicine Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Anti-heat Stroke Medicine in 2025
Figure 78. Manufacturing Process Analysis of Anti-heat Stroke Medicine
Figure 79. Industry Chain Structure of Anti-heat Stroke Medicine
Figure 80. Channels of Distribution
Figure 81. Global Anti-heat Stroke Medicine Sales Market Forecast by Region (2026-2031)
Figure 82. Global Anti-heat Stroke Medicine Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Anti-heat Stroke Medicine Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Anti-heat Stroke Medicine Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Anti-heat Stroke Medicine Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Anti-heat Stroke Medicine Revenue Market Share Forecast by Application (2026-2031)
